Published in Infection on January 01, 1983
Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. J Antimicrob Chemother (1978) 4.83
Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1979) 3.51
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 3.29
The in-vitro activity of ceftazidime against clinically important pathogens. J Antimicrob Chemother (1981) 1.69
The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers. J Antimicrob Chemother (1981) 0.93
The in-vitro activity of ceftazidime compared with that of other cephalosporins. J Antimicrob Chemother (1981) 0.88
[Animal studies on antibacterial activity of 10 cephalosporins (author's transl)]. Zentralbl Bakteriol Orig A (1978) 0.87
[Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin]. Arzneimittelforschung (1981) 0.83
Metabolic fate of [14C]-ceftizoxime, a parenteral cephalosporin antibiotic, in rats and dogs. Arzneimittelforschung (1980) 0.82
American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog (1990) 3.18
Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun (1992) 2.69
Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol (2001) 2.43
Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J (2000) 2.15
Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection (1994) 2.13
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 2.05
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
Osteoarthritis of the knee: comparison of radiography, CT, and MR imaging to assess extent and severity. AJR Am J Roentgenol (1991) 1.91
Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol (1991) 1.89
Nitrogen-containing ligands for asymmetric homogeneous and heterogeneous catalysis. Chem Rev (2000) 1.83
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis (2005) 1.83
CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61
Updating the Read Codes: user-interactive maintenance of a dynamic clinical vocabulary. J Am Med Inform Assoc (1997) 1.60
Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol (1997) 1.55
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54
Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun (2000) 1.53
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother (1994) 1.49
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1996) 1.48
Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect Immun (1989) 1.47
Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun (1995) 1.47
[New therapeutic strategies for community acquired pneumonia]. Internist (Berl) (2005) 1.43
Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcus carnosus and contribution of the enzyme to virulence. Infect Immun (1989) 1.43
Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun (1986) 1.43
Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years. Am J Hematol (1989) 1.42
Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome. J Clin Gastroenterol (1989) 1.41
Glomerular proteinuria as an early sign of renal-transplant rejection. Clin Nephrol (1991) 1.39
Genome analysis of Legionella ssp. by orthogonal field alternation gel electrophoresis (OFAGE). FEMS Microbiol Lett (1990) 1.39
The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res (1995) 1.37
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J (2007) 1.34
Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis (2007) 1.31
Overexpresssion of a Legionella pneumophila homologue of the E. coli regulator csrA affects cell size, flagellation, and pigmentation. Int J Med Microbiol (2001) 1.29
The HSM sentence test as a tool for evaluating the speech understanding in noise of cochlear implant users. Am J Otol (1997) 1.29
Properties of Escherichia coli strains of serotype O6. Infection (1996) 1.26
A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol (2009) 1.24
Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol (1994) 1.23
Temperature-dependent expression of flagella in Legionella. J Gen Microbiol (1991) 1.22
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20
Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infect Immun (2000) 1.19
Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother (1984) 1.17
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin Diagn Lab Immunol (1997) 1.17
Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun (1996) 1.17
Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother (2006) 1.16
Hemagglutinating and adherence properties of Staphylococcus saprophyticus: epidemiology and virulence in experimental urinary tract infection of rats. FEMS Microbiol Immunol (1988) 1.15
Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy? Transplantation (1998) 1.14
The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem (1994) 1.14
Bilateral posterior fracture-dislocation of the shoulders: management by bilateral shoulder hemiarthroplasties. J Orthop Trauma (1995) 1.13
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother (1996) 1.12
CAPNETZ-community-acquired pneumonia competence network. Infection (2004) 1.11
[Fatal arterial bleeding as complication of tracheostomy]. Dtsch Z Gesamte Gerichtl Med (1968) 1.10
[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol (2011) 1.08
De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells. Infect Immun (1996) 1.06
Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect (1997) 1.06
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis. Infection (1999) 1.04
Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun (1993) 1.04
Cloning, genetic analysis, and nucleotide sequence of a determinant coding for a 19-kilodalton peptidoglycan-associated protein (Ppl) of Legionella pneumophila. Infect Immun (1991) 1.04
[Longitudinal study of 24-hour blood pressure behavior in pregnancy and puerperium in patients with normal pregnancy, pre-eclampsia and HELLP syndrome]. Z Geburtshilfe Neonatol (1996) 1.01
Diagnosis of ornithosis by cell culture and polymerase chain reaction in a patient with chronic pneumonia. Clin Infect Dis (1995) 0.99
Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats. J Antimicrob Chemother (1990) 0.99
Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection. Infect Immun (1997) 0.99
Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses (1996) 0.99
Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1994) 0.98
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother (1998) 0.97
[S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie (2005) 0.97
Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol (1998) 0.96
Exophiala mesophila spec. nov. Mycoses (1996) 0.96
Forty-two-years later: the outcome of childhood-onset schizophrenia. J Neural Transm (Vienna) (2006) 0.96
Aggregation substance-mediated adherence of Enterococcus faecalis to immobilized extracellular matrix proteins. Microb Pathog (2001) 0.95
Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry (1998) 0.95
Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun (1992) 0.94
Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br J Pharmacol (2007) 0.94
Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun (2001) 0.94
A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin. Mycoses (1995) 0.93
Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect (2007) 0.93
Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J Med Microbiol (1996) 0.93
In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases. Arzneimittelforschung (1988) 0.92
Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis (2003) 0.92
Tamm-Horsfall protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular epithelial cells. Exp Nephrol (1997) 0.91
Identification of 27-oxo-octacosanoic acid and heptacosane-1,27-dioic acid in Legionella pneumophila. FEMS Microbiol Lett (1992) 0.91
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother (1994) 0.91
[On the 100th birthday of Ernst Jeckelin]. Pathologe (2003) 0.91
Effects of antipsychotics and vitamin C on the formation of reactive oxygen species. J Psychopharmacol (2009) 0.90
Childhood-onset schizophrenia: history of the concept and recent studies. Schizophr Bull (1994) 0.90
Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother (2009) 0.90
A randomised comparison of bilateral recession versus unilateral recession-resection as surgery for infantile esotropia. Br J Ophthalmol (2009) 0.90
High pressure equilibrium studies on the dissociation-association of E. coli ribosomes. FEBS Lett (1976) 0.90
[Experimental studies on the renal tolerance of cefuroxime (author's transl)]. Infection (1977) 0.90
MR imaging of the arthritic knee: improved discrimination of cartilage, synovium, and effusion with pulsed saturation transfer and fat-suppressed T1-weighted sequences. Radiology (1994) 0.89
Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol (1993) 0.89
Genetics of Escherichia coli uropathogenicity: analysis of the O6:K15:H31 isolate 536. Zentralbl Bakteriol (1992) 0.89
Inversion lateral ankle trauma: differential diagnosis, review of the literature, and prospective study. J Foot Surg (1987) 0.89
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol (1999) 0.89
Endocarditis caused by Bacillus circulans. Infection (1992) 0.89